Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Söderström, M.
Right arrow Articles by Fredriksson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Söderström, M.
Right arrow Articles by Fredriksson, S.
NEUROLOGY 1993;43:1215
© 1993 American Academy of Neurology

Optic neuritis and multiple sclerosis

Anti-MBP and anti-MBP peptide antibody-secreting cells are accumulated in CSF

Mats Söderström, MD, Hans Link, MD, PhD, Zhenyi Xu, MD and Sten Fredriksson, MD, PhD

Departments of Neurology and Ophthalmology, Karolinska Institutet, Huddinge Hospital. Stockholm, Sweden.

Monosymptomatic unilateral optic neuritis (ON) is a common first manifestation of multiple sclerosis (MS) in which increased numbers of autoimmune T and B cells, recognizing different myelin autoantigens including myelin basic protein (MBP) and its peptides, have been implicated in a hypothetical immunopathogenesis. Using an immunospot assay to detect specific antibodies secreted by individual cells, we analyzed the B-cell repertoire to MBP and its amino acid residues 1-20, 63-88, 110-128, and 148-165 in blood and CSF from patients with ON and MS, and from controls. There were cells secreting IgG antibodies to MBP and the four peptides in blood at mean numbers of 0.9 to 4.6 per 105 mononuclear cells, without differences between the three patient groups. Mostly, more than 100-fold more B cells with these specificities per 105 cells were found in CSF from the patients with ON and MS, without differences between these two groups but with many fewer in CSF from controls. None of the four included MBP peptides represented an immunodominant B-cell epitope in either ON or MS, and the B-cell response was not more restricted in ON than in MS. The autonomy of the autoimmune B-cell response in CSF was further supported by the pronounced asynchrony of the repertoire to the four MBP peptides in CSF compared with blood in individual patients. The large numbers of MBP- and MBP peptide-reactive B cells in CSF in early MS, as manifested by ON, could play a major role in the immunopathogenesis and perpetuation of MS. Alternatively, they could represent myelin breakdown or restoration.

Address correspondence and reprint requests to Dr. Mats Söderström, Department of Ophthalmology, Karolinska Institutet, Huddinge Hospital, S-141 86 Huddinge, Sweden.

Supported by grants from the Swedish Medical Research Council, the Swedish MS Society (NHR), and Karolinska Institutet.

Received August 13,1992. Accepted for publication in final form October 28, 1992.




This article has been cited by other articles:


Home page
NeurologyHome page
J. Correale and M. Fiol
Activation of humoral immunity and eosinophils in neuromyelitis optica
Neurology, December 28, 2004; 63(12): 2363 - 2370.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
M. Bakhiet, V. Ozenci, C. Withagen, M. Mustafa, S. Fredrikson, and H. Link
A New Cell Enzyme-Linked Immunosorbent Assay Demonstrates Gamma Interferon Suppression by Beta Interferon in Multiple Sclerosis
Clin. Vaccine Immunol., May 1, 1999; 6(3): 415 - 419.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.